Travel-Related Economic Burden of Chimeric Antigen Receptor T Cell Therapy Administration by Site of Care
mediaposted on 2021-07-16, 10:36 authored by Adis Rapid Journals on behalf of:, Sophie Snyder, Tina Albertson, Jacob Garcia, Matthew Gitlin, Monika P. Jun
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.